ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

Protocols Approved During the Month of June 2002

July 26, 2002

In Brief: Survivors Day Scheduled For April 30; Miami Center Names Changed; NCI’s Adamson Honored

April 14, 1989

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999